Pathways Bioscience Announces Publication of Scientific Paper on the Complexity of the Nrf2 Transcription Factor Pathway Brooks HybertsonFebruary 14, 2023
Pathways Bioscience Announces Scientific Publication of Collaborative Research on Aging, Nrf2, Muscles, and Mitochondria Brooks HybertsonDecember 9, 2022
Pathways Bioscience Announces Issuance of International Patents for Their Nrf2-Activating Dietary Supplements Brooks HybertsonOctober 18, 2022
Pathways Bioscience Announces Issuance of U.S. Patent for Their Nrf2-Activating Dietary Supplements Brooks HybertsonOctober 3, 2022
Pathways Bioscience Announces Scientific Publication of Collaborative Research on Helianthemum nummularium Alpine Plant Brooks HybertsonJuly 17, 2020
Pathways Bioscience Announces New Peer-Reviewed Publication on Nrf2-Activation and Antiviral Gene Regulation by PB125 Brooks HybertsonJune 15, 2020
Pathways Bioscience Announces Peer-Reviewed Publication of Research Utilizing Nrf2-Activation Effects of PB125 Brooks HybertsonJuly 9, 2019
Pathways Bioscience Announces Peer-Reviewed Publication of Work Utilizing Nrf2-Activation Effects of PB123 Brooks HybertsonMay 24, 2019
Pathways Bioscience Announces Peer-Reviewed Publication Highlighting Nrf2-Activation Effects of PB125 Brooks HybertsonMay 9, 2019
Pathways Bioscience Co-Founder Presents at Experimental Biology 2019 Nrf2 Symposium Brooks HybertsonMay 1, 2019
Pathways Bioscience Dietary Supplement Selected for Testing by National Institute on Aging Brooks HybertsonMay 17, 2018
Pathways Bioscience Announces NIH National Institute on Aging SBIR Phase I Award to Investigate Potential Anti-Aging Benefits of Nrf2 Activation Brooks HybertsonMarch 16, 2018
Pathways Bioscience Announces National Institutes of Health NIDCR SBIR Phase I Award to Develop Potential Oral Mucositis Treatment by Nrf2 Activation Brooks HybertsonMay 9, 2017Comment
